Patents by Inventor Phillip Branch Chappell

Phillip Branch Chappell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
    Publication number: 20080132538
    Abstract: A method of treating overactive bladder disorders characterized by involuntary neurogenic detrusor contractions associated with the pathology of multiple sclerosis by administering fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, by administering compounds of the formula wherein Q, X1, X2 and X3 are as defined below, and their pharmaceutically acceptable salts.
    Type: Application
    Filed: August 5, 2004
    Publication date: June 5, 2008
    Inventors: Phillip Branch Chappell, Brian Thomas O'Neill, Mario David Saltarelli
  • Combination treatment for depression, anxiety and psychosis
    Publication number: 20040048869
    Abstract: The present invention relates to a method of treating depression, anxiety or psychosis in a mammal, including a human, by administering to the mammal a D4 receptor antagonist in combination with an antidepressant or an anxiolytic agent. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a D4 receptor antagonist and an antidepressant or an anxiolytic agent.
    Type: Application
    Filed: September 3, 2003
    Publication date: March 11, 2004
    Applicant: Pfizer Inc
    Inventors: Phillip Branch Chappell, Stevin Howard Zorn
  • Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
    Publication number: 20030114439
    Abstract: The present invention relates to methods of treating various CNS and other disorders by adminstering fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, by administering compounds of the formula 1
    Type: Application
    Filed: July 29, 2002
    Publication date: June 19, 2003
    Applicant: Pfizer Inc.
    Inventors: Phillip Branch Chappell, Brian Thomas O'Neill, Mario David Saltarelli
  • Aralkyl and aralkylidene heterocyclic lactams and imides
    Patent number: 6423708
    Abstract: The present invention relates to compounds of the formula I wherein R1, R2, R3, X, Y and the dashed line are as defined in the specification, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use as psychotherapeutic agents.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: July 23, 2002
    Assignee: Pfizer INC
    Inventors: Megan Ann Gibbs, Harry Ralph Howard, Jeffrey Scott Sprouse, Joel Barry Schachter, Phillip Branch Chappell
  • Combination treatment for depression, anxiety and psychosis
    Publication number: 20020094986
    Abstract: The present invention relates to a method of treating depression, anxiety or psychosis in a mammal, including a human, by administering to the mammal a D4 receptor antagonist in combination with an antidepressant or an anxiolytic agent. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a D4 receptor antagonist and an antidepressant or an anxiolytic agent.
    Type: Application
    Filed: December 5, 2001
    Publication date: July 18, 2002
    Applicant: Pfizer Inc
    Inventors: Phillip Branch Chappell, Stevin Howard Zorn
  • Aralkyl and aralkylidene heterocyclic lactams and imides
    Publication number: 20020049214
    Abstract: The present invention relates to compounds of the formula I 1
    Type: Application
    Filed: December 8, 2000
    Publication date: April 25, 2002
    Inventors: Megan Ann Gibbs, Harry Ralph Howard, Jeffrey Scott Sprouse, Joel Barry Schachter, Phillip Branch Chappell
  • Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
    Publication number: 20020035147
    Abstract: The present invention relates to methods of treating various CNS and other disorders by adminstering fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, by administering compounds of the formula 1
    Type: Application
    Filed: May 3, 2001
    Publication date: March 21, 2002
    Inventors: Phillip Branch Chappell, Brian Thomas O'Neill, Mario David Saltarelli